Role of Lipid Metabolism Reprogramming in the Progression and Drug Resistance of Ovarian Cancer
QIN Chen
ZHANG Wei
LI Li
Abstract：Ovarian cancer is a gynecological malignant tumor with the highest mortality rate,and its recurrence and drug resistance are closely related to lipid metabolism reprogramming.Studies have shown that abnormal lipid metabolism promotes the synthesis of fatty acid and cholesterol through the abnormal activation of core metabolic enzymes,alters the fluidity of the cell membrane,and drives oncogenic signal transduction.Meanwhile,ascites,exosomes,and immune cells in the tumor microenvironment further enhance tumor metastasis and platinum resistance through lipid transport and metabolic remodeling.Moreover,lipid metabolism interacts with epigenetic modifications and immune checkpoint regulation to reshape the immune response and induce immune escape.These mechanisms work together to maintain the survival,invasion,and drug-resistant phenotypes of cancer cells.Therefore,targeting the key nodes or related pathways of lipid metabolism is not only expected to become molecular markers for the diagnosis and prognosis of ovarian cancer,but also provides a theoretical basis for the combined treatment strategy of metabolic intervention and immune regulation,showing important clinical translational value.
Keywords：Ovarian neoplasmsLipid metabolismTumor microenvironmentDrug resistancePhenotype
Publication Date：2025-10-15
Online Publishing Date：2025-11-26(First online date of this platform, not the publication date of the document)
Pages：6( 492-497 )